Further investigation revealed that IL-8 promotes tumor stemness in ICC, accompanied by upregulation of CD133, CD44, and OCT-4 expression, while either SB225002 or JSH-23 could inhibit the effect of IL-8 (Figures 4F–I). Here, CD44 is linked to intrahepatic cholangiocarcinoma.